期刊文献+

胞嘧啶脱氨酶基因修饰神经干细胞及其表达的离体实验研究 被引量:3

Study of neural stem cells modified by cytosine deaminase gene and its expression in vitro
在线阅读 下载PDF
导出
摘要 目的 探讨胞嘧啶脱氨酶 (Cytimidinedeaminase ,CD)基因修饰神经干细胞及其基因表达。方法 通过构建真核表达质粒pCMVCD ,限制性内切酶消化鉴定后 ,采用Lipofectamine 2 0 0 0脂质体介导法转染新生大鼠室管膜下区神经干细胞 (Neuralstemcells ,NSCs) ,G418筛选阳性克隆 ,加入不同浓度的 5 氟胞嘧啶 ( 5 Flourocytosine ,5 FC) ,MTT比色法测定NSCs的生存率。结果 本实验成功地培养并鉴定了神经干细胞 ,并将CD基因成功地转染了神经干细胞 ,G418阳性NSCs对低浓度 5 FC高度敏感。 Objective To investigate neural stem cells (NSCs) modified by cytosine deaminase (CD) gene and its expression in vitro . Methods Eukaryotic expression plasmid pCMVCD was constructed, and identified by restriction endoenzyme digestion. CD gene was transfected into NSCs from new born Wistar rats using Lipofectamine2000. Positive clones (named NSCs/CD cells) were screened by G418 presence. 5 Fluorocytosine (5 FC) administration of different concentrations were incubated with NSCs/CD cells. NSCs/CD cells viability ratios were measured by MTT assay. Results NSCs cell culture and identification were carried out, transduction of CD gene was also successfully proceeded. Gene transfer made G418 positive NSCs (NSCs/CD cells) highly sensitive to 5 FC. Conclusion Study of NSCs modified by cytosine CD gene and its expression in vitro plays an important role in the studies of stem cell therapy in vivo .
出处 《第三军医大学学报》 CAS CSCD 北大核心 2003年第11期945-947,共3页 Journal of Third Military Medical University
基金 国家自然科学基金资助重点项目 ( 30 130 110 )
关键词 胞嘧啶脱氨酶 基因转染 基因表达 神经干细胞 cytosine deaminase gene transfection gene expression neural stem cells
  • 相关文献

参考文献15

  • 1Reynolds B A, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system[J]. Science, 1992,255(5052): 1707-1710.
  • 2Ling Z D, Potter E D, Lipton J W, et al. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines[J]. Exp Neurol, 1998,149(2): 411-423.
  • 3Gage F H. Mammalian neural stem cell[J]. Science, 2000,287(5457): 1433-1438.
  • 4Rubio F J, Kokaia Z, Arco A D, et al. BDNF gene transfer to the mammalian brain using CNS-derived neural precursors[J]. Gene Ther, 1999,6(11): 1851-1866.
  • 5Yang H, Mujtaba T, Venkatraman G, et al. Region-specific differentiation of neural tube-derived neuronal restricted progenitor cells after heterotopic transplantation[J]. Proc Natl Acad Sci USA, 2000,97(24): 13366-13371.
  • 6Yoshimura I, Suzuki S, Tadakuma T, et al. Suicide gene therapy on LNCaP human prostate cancer cells[J]. Int J Urol, 2001,8:S5-S8.
  • 7任圣俊,蒋惠秋,顾健人.大肠杆菌胞嘧啶脱氨酶基因克隆及其原核表达载体构建、表达[J].科学通报,1997,42(19):2039-2046. 被引量:1
  • 8Austin E A, Huber B E. A first step in development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase[J]. Mol Pharmacol, 1993,43(3): 380-387 .
  • 9Raymon H K, Thode S, Gage F H. Application of ex vivo gene therapy in the treatment of Parkinson's disease[J]. Exp Neurol, 1997,144(1): 82-91.
  • 10Sugaya K, Brannen C L. Stem cell strategies for neuroreplacement therapy in Alzheimer's disease[J]. Med Hypotheses, 2001,57(6): 697-700.

二级参考文献1

  • 1李振,恶性肿瘤的化学治疗与免疫治疗,1990年

同被引文献16

  • 1黄嘉凌,刘燕艳,方壮伟,申权,刘然义,吕明德.HSV-TK/CD基因联合IL-12基因体内治疗肝癌[J].肿瘤,2004,24(5):467-469. 被引量:9
  • 2洪涛,孙华,蒋丽萍,何安慰,卢明巍.全反式维甲酸诱导脑胶质瘤化疗的旁观者效应[J].中华实验外科杂志,2005,22(3):379-379. 被引量:6
  • 3Benedetti S,Dimeco F,Pollo B,et al.Limited efficacy of the HSVTK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene[J].Hum Gene Ther,1997,8(11):1345-1353.
  • 4Drozdzik M,Qian C,Xie X,et al.Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma[J].J Hepatol,2000,32(2):279-286.
  • 5Roy L,Holle W,Song E,et al.Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro[J].Anti-cancer Res,2002,22(6A):3185-3189.
  • 6Barzon L,Zanusso M,Colombo F,et al.Clinical trials of gene therapy,virotherapy,and immunotherapy for malignant gliomas[J].J Cancer Gene Ther,2006,13(6):539-554.
  • 7Alexandrova R.Experimental strategies in gene therapy of cancer[J].J Buon,2009,14(Suppl 1):S23-32.
  • 8Chen H Y,Shao C J,Chen F R,et al.Role of ERCC1 pro-moter hypermethylation in drug resistance to cisplatin in human gliomas[J].Int J Cancer,2010,126(8):1944-1954.
  • 9Hopkins K,Chandler C,Eatough J,et al.Direct injection of 90Y Mo Abs into glioma tumor resection cavities leads to limited diffusion of the radioimmunoconjugates into normal brain parenchyma:a model to estimate absorbed radiation dose[J].Int J Radiat Oncol Biol Phys,1998,40(4):835-844.
  • 10Ying Wang,Hui-Xiong Xu,Ming-De Lu,Qing Tang.Expression of thymidine kinase mediated by a novel non-viral delivery system under the control of vascular endothelial growth factor receptor 2 promoter selectively kills human umbilical vein endothelial cells[J].World Journal of Gastroenterology,2008,14(2):224-230. 被引量:9

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部